Kryger Capital’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-42,018
Closed -$421K 125
2022
Q2
$421K Sell
42,018
-2,065
-5% -$20.6K 0.03% 195
2022
Q1
$441K Buy
+44,083
New +$438K 0.03% 231

Other funds holding IQMD

Kryger Capital's IQMD Position: Q3 2022 in Review

Kryger Capital sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q3 2022, closing a stake of 42,018 shares — an estimated $421K sold.

Kryger Capital first reported a position in IQMD in Q1 2022 and held it in 2 quarters. The position peaked at $441K in Q1 2022. 58 funds tracked by Wall St. Rank hold IQMD as of Q3 2022.

  • Kryger Capital reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Kryger Capital sold 42,018 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $421K.
  • Kryger Capital first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 2 quarters.
  • Kryger Capital's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $441K in Q1 2022.
  • 58 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on Kryger Capital's 13F filing for Q3 2022, filed 10 Nov 2022.